Sou Hu Cai Jing·2025-08-14 15:51Core Viewpoint - *ST Suwu's stock price has fallen below 1 yuan per share, triggering a delisting risk warning from the Shanghai Stock Exchange [1][3]. Group 1: Stock Performance and Delisting Risk - On August 14, *ST Suwu's stock closed at 0.99 yuan per share, which is below the 1 yuan threshold [1]. - According to the Shanghai Stock Exchange rules, if a company's stock price remains below 1 yuan for 20 consecutive trading days, it may face delisting [3]. - *ST Suwu has previously issued multiple warnings regarding potential delisting due to significant internal control issues [5]. Group 2: Regulatory Actions and Financial Reporting Issues - On July 13, *ST Suwu received a notice from the China Securities Regulatory Commission regarding administrative penalties, which could lead to a major violation delisting [5]. - The company has been found to have inflated revenue and profits through non-substantive trade activities with related companies, leading to false records in its annual reports from 2020 to 2023 [5]. - The 2024 financial report received an "unable to express an opinion" from the auditing firm, resulting in a delisting risk warning from the exchange [5]. Group 3: Related Party Transactions - On May 6, *ST Suwu announced that its controlling shareholder's related parties had occupied company funds, exceeding 5% of the latest audited net assets [6]. - This situation has led to additional risk warnings for the company's stock [6]. Group 4: Legal Disputes and Claims - On August 11, *ST Suwu's subsidiary, Datuo Medical, initiated arbitration against Regen Biotech for breach of contract, seeking 1.6 billion yuan in damages [8]. - The dispute centers around the exclusive distribution rights for the "AestheFill" product in China, which Regen attempted to revoke [9]. Group 5: Company Overview - *ST Suwu's main business includes pharmaceuticals and medical aesthetics, focusing on drug development and high-end aesthetic injection products [10]. - As of August 14, the company's stock price was 0.99 yuan, with a total market capitalization of 700 million yuan [10]. - As of the end of Q1 2025, *ST Suwu had approximately 86,200 shareholders, reflecting a significant increase from the previous quarter [12].